Trial Archives: Completed

---

Protocol EFC5892, Sanofi Aventis, Generalized Anxiety Disorder

- March 24, 2011

Protocol EFC5582, Sanofi Aventis, Generalized Anxiety Disorder

- March 24, 2011

Protocol DAC-1012, Protein Design Labs, Relapsing Multiple Sclerosis

- March 24, 2011

Protocol A0081071, Pfizer, Diabetic Peripheral Neuropathy

- March 24, 2011

Protocol A6061029 Open Label, Pfizer, Post Herpetic Neuralgia

- March 24, 2011

Protocol A6061026, Pfizer, Post Herpetic Neuralgia

- March 24, 2011

Protocol A3191338, Pfizer, Chronic Low Back Pain

- March 24, 2011

Protocol A3191165, Pfizer, Low Back Pain

- March 24, 2011

Protocol A0081071, Pfizer, Diabetic Neuropathy

- March 24, 2011

Protocol CRIT124E2305, Novartis, Pediatric Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol CAGO178A2303, Novartis, Major Depressive Disorder

- March 24, 2011

Protocol NRP104-304 Open Label, New River Pharmaceuticals, Adult Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol NRP104-303, New River Pharmaceuticals, Adult Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol C116, Neurogesx Inc., Post Herpetic Neuralgia

- March 24, 2011

Protocol EMR 62-225-030 Open Label, Merck, Parkinson’s Disease

- March 24, 2011